Provided by Tiger Trade Technology Pte. Ltd.

ResMed

235.04
+0.44000.19%
Post-market: 234.79-0.2500-0.11%19:49 EDT
Volume:891.98K
Turnover:209.48M
Market Cap:33.14B
PE:22.53
High:236.86
Open:236.59
Low:233.15
Close:234.60
52wk High:277.67
52wk Low:180.27
Shares:141.00M
Float Shares:140.00M
Volume Ratio:0.93
T/O Rate:0.64%
Dividend:2.40
Dividend Rate:1.02%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:5.03
PE(LYR):22.53

Loading ...

Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 07, 2021

Major Issues Report

8-K/A [Amend] - Current report
Sep 13, 2021

Major Issues Report

8-K - Current report
Aug 27, 2021

Major Issues Report

8-K - Current report
Aug 19, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 17, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 05, 2021

Major Issues Report

8-K - Current report
May 21, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 30, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 29, 2021

Major Issues Report

8-K - Current report
Mar 30, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 29, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jan 28, 2021

Major Issues Report

8-K - Current report
Nov 20, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Major Issues Report

8-K/A [Amend] - Current report
Oct 30, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]